Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling

Biochemical Pharmacology

Volumn 87, Issue 3, 2014, Pages 424-434

  Cao, Hui Hui ^a   Tse, Anfernee Kai Wing ^a   Kwan, Hiu Yee ^a   Yu, Hua ^a   Cheng, Chi Yan ^a   Su, Tao ^a   Fong, Wang Fun ^a   Yu, Zhi Ling ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Apoptosis; Invasion; Melanoma; Migration; STAT3

Indexed keywords

ANTINEOPLASTIC AGENT; GELATINASE A; GELATINASE B; JANUS KINASE 2; PROTEIN MCL 1; QUERCETIN; STAT3 PROTEIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR INVASION; TUMOR VOLUME;

APOPTOSIS; INVASION; MELANOMA; MIGRATION; STAT3;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; QUERCETIN; RANDOM ALLOCATION; STAT3 TRANSCRIPTION FACTOR;

EID: 84892933053     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.11.008     Document Type: Article

References (49)

1. R. Siegel, C. DeSantis, K. Virgo, K. Stein, A. Mariotto, and T. Smith et al. Cancer treatment and survivorship statistics, 2012 CA Cancer J Clin 62 2012 220 241
2. D.L. Cummins, J.M. Cummins, H. Pantle, M.A. Silverman, A.L. Leonard, and A. Chanmugam Cutaneous malignant melanoma Mayo Clin Proc 81 2006 500 507
3. Z.H. Chi, S.M. Li, X.N. Sheng, L. Si, C.L. Cui, and M. Han et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases BMC Cancer 11 2011 10
4. L. Serrone, M. Zeuli, F.M. Sega, and F. Cognetti Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview J Exp Clin Cancer Res 19 2000 21 34 (Pubitemid 30305516)
5. L.M. Alwan, K. Grossmann, D. Sageser, J. Van Atta, N. Agarwal, and J.A. Gilreath Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma Target Oncol 2013 10.1007/s11523-013-0276-7 [Epub ahead of print]
6. M.B. Atkins, M.T. Lotze, J.P. Dutcher, R.I. Fisher, G. Weiss, and K. Margolin et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993 J Clin Oncol 17 1999 2105 2116 (Pubitemid 29318842)
7. P. Lopez-Bergami, B. Fitchman, and Z. Ronai Understanding signaling cascades in melanoma Photochem Photobiol 84 2008 289 306 (Pubitemid 351424029)
8. P.A. Johnston, and J.R. Grandis STAT3 signaling: anticancer strategies and challenges Mol Interv 11 2011 18 26
9. K. Al Zaid Siddiquee, and J. Turkson STAT3 as a target for inducing apoptosis in solid and hematological tumors Cell Res 18 2008 254 267 (Pubitemid 351206162)
10. G. Niu, T. Bowman, M. Huang, S. Shivers, D. Reintgen, and A. Daud et al. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth Oncogene 21 2002 7001 7010 (Pubitemid 35252974)
11. G. Niu, R. Heller, R. Catlett-Falcone, D. Coppola, M. Jaroszeski, and W. Dalton et al. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo Cancer Res 59 1999 5059 5063 (Pubitemid 29503958)
12. G. Niu, K.L. Wright, M. Huang, L. Song, E. Haura, and J. Turkson et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Oncogene 21 2002 2000 2008 (Pubitemid 34270888)
13. T.X. Xie, F.J. Huang, K.D. Aldape, S.H. Kang, M. Liu, and J.E. Gershenwald et al. Activation of stat3 in human melanoma promotes brain metastasis Cancer Res 66 2006 3188 3196
14. Q. Xu, J. Briggs, S. Park, G. Niu, M. Kortylewski, and S. Zhang et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways Oncogene 24 2005 5552 5560 (Pubitemid 43119350)
15. L. Liu, S. Nam, Y. Tian, F. Yang, J. Wu, and Y. Wang et al. 6-Bromoindirubin-3′-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells Cancer Res 71 2011 3972 3979
16. L. Liu, M. Kritsanida, P. Magiatis, N. Gaboriaud, Y. Wang, and J. Wu et al. A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling Cancer Biol Ther 13 2012 1255 1261
17. M.Z. Kamran, and R.P. Gude Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway Biomed Pharmacother 67 2013 399 405
18. T. Okamoto Safety of quercetin for clinical application (Review) Int J Mol Med 16 2005 275 278
19. R. Gugler, M. Leschik, and H.J. Dengler Disposition of quercetin in man after single oral and intravenous doses Eur J Clin Pharmacol 9 1975 229 234
20. E.E. Mendoza, and R. Burd Quercetin as a systemic chemopreventative agent: structural and functional mechanisms Mini Rev Med Chem 11 2011 1216 1221
21. M. Russo, C. Spagnuolo, I. Tedesco, S. Bilotto, and G.L. Russo The flavonoid quercetin in disease prevention and therapy: facts and fancies Biochem Pharmacol 83 2012 6 15
22. E. Middleton Jr., C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol Rev 52 2000 673 751
23. S. Caltagirone, C. Rossi, A. Poggi, F.O. Ranelletti, P.G. Natali, and M. Brunetti et al. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential Int J Cancer 87 2000 595 600 (Pubitemid 30639822)
24. M. Piantelli, C. Rossi, M. Iezzi, R. La Sorda, S. Iacobelli, and S. Alberti et al. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions J Cell Physiol 207 2006 23 29
25. X.M. Zhang, J. Chen, Y.G. Xia, and Q. Xu Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-alpha and translocating PKC-delta Cancer Chemother Pharmacol 55 2005 251 262 (Pubitemid 40142890)
26. X. Zhang, Q. Xu, and I. Saiki Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression Clin Exp Metastasis 18 2000 415 421 (Pubitemid 32588622)
27. M. Piantelli, N. Maggiano, R. Ricci, L.M. Larocca, A. Capelli, and G. Scambia et al. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells J Invest Dermatol 105 1995 248 253
28. M.R. Loizzo, A. Said, R. Tundis, U.W. Hawas, K. Rashed, and F. Menichini et al. Antioxidant and antiproliferative activity of Diospyros lotus L. extract and isolated compounds Plant Foods Hum Nutr 64 2009 264 270
29. K. Rosner, C. Ropke, V. Pless, and G.L. Skovgaard Late type apoptosis and apoptosis free lethal effect of quercetin in human melanoma Biosci Biotechnol Biochem 70 2006 2169 2177 (Pubitemid 44451894)
30. J. Michaud-Levesque, N. Bousquet-Gagnon, and R. Beliveau Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration Exp Cell Res 318 2013 925 935
31. Y. Qin, L.Y. He, Y. Chen, W.Y. Wang, X.H. Zhao, and M.Y. Wu Quercetin affects leptin and its receptor in human gastric cancer MGC-803 cells and JAK-STAT pathway Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 28 2012 12 16
32. S. Nam, J. Xie, A. Perkins, Y. Ma, F. Yang, and J. Wu et al. Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells Mol Oncol 6 2012 484 493
33. F. Capozza, C. Trimmer, R. Castello-Cros, S. Katiyar, D. Whitaker-Menezes, and A. Follenzi et al. Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration Cancer Res 72 2012 2262 2274
34. W. Zhang, B. Tang, Q. Huang, and Z. Hua Galangin inhibits tumor growth and metastasis of B16F10 melanoma J Cell Biochem 114 2013 152 161
35. I. Yajima, M.Y. Kumasaka, N.D. Thang, Y. Goto, K. Takeda, and O. Yamanoshita et al. RAS/RAF/MEK/ERK and PI3K/PTEN/AKT signaling in malignant melanoma progression and therapy Dermatol Res Pract 2012 2012 354191
36. L. Zhuang, C.S. Lee, R.A. Scolyer, S.W. McCarthy, X.D. Zhang, and J.F. Thompson et al. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma Mod Pathol 20 2007 416 426 (Pubitemid 46482365)
37. J.F. Bromberg, M.H. Wrzeszczynska, G. Devgan, Y. Zhao, R.G. Pestell, and C. Albanese et al. Stat3 as an oncogene Cell 98 1999 295 303 (Pubitemid 29380565)
38. M. Harwood, B. Danielewska-Nikiel, J.F. Borzelleca, G.W. Flamm, G.M. Williams, and T.C. Lines A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties Food Chem Toxicol 45 2007 2179 2205 (Pubitemid 47451573)
39. S. Egert, S. Wolffram, A. Bosy-Westphal, C. Boesch-Saadatmandi, A.E. Wagner, and J. Frank et al. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans J Nutr 138 2008 1615 1621
40. P.C. Hollman, M. vd Gaag, M.J. Mengelers, J.M. van Trijp, J.H. de Vries, and M.B. Katan Absorption and disposition kinetics of the dietary antioxidant quercetin in man Free Radic Biol Med 21 1996 703 707 (Pubitemid 26331100)
41. P.C. Hollman, J.M. van Trijp, M.J. Mengelers, J.H. de Vries, and M.B. Katan Bioavailability of the dietary antioxidant flavonol quercetin in man Cancer Lett 114 1997 139 140 (Pubitemid 27140094)
42. C. Morand, V. Crespy, C. Manach, C. Besson, C. Demigne, and C. Remesy Plasma metabolites of quercetin and their antioxidant properties Am J Physiol 275 1998 R212 R219
43. Z.J. Sun, G. Chen, X. Hu, W. Zhang, Y. Liu, and L.X. Zhu et al. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin Apoptosis 15 2010 850 863
44. B.B. Aggarwal, A.B. Kunnumakkara, K.B. Harikumar, S.R. Gupta, S.T. Tharakan, and C. Koca et al. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171 2009 59 76
45. X. Jiang, J. Zhou, A. Giobbie-Hurder, J. Wargo, and F.S. Hodi The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition Clin Cancer Res 19 2013 598 609
46. A. Vultur, J. Villanueva, C. Krepler, G. Rajan, Q. Chen, and M. Xiao et al. MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines Oncogene 2013 10.1038/onc.2013.131 [Epub ahead of print]
47. M.L. Hartman, and M. Czyz Anti-apoptotic proteins on guard of melanoma cell survival Cancer Lett 331 2013 24 34
48. P. Redondo, P. Lloret, M. Idoate, and S. Inoges Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression Clin Exp Dermatol 30 2005 541 545 (Pubitemid 41076024)
49. T.X. Xie, D. Wei, M. Liu, A.C. Gao, F. Ali-Osman, and R. Sawaya et al. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis Oncogene 23 2004 3550 3560 (Pubitemid 38658421)